Food and Drug Administration Safety and Innovation Act

Floor Speech

BREAK IN TRANSCRIPT

Mrs. GILLIBRAND. Madam President, earlier this week I introduced the Cody Miller Initiative for Safe Prescriptions Act. The legislation would require the Food and Drug Administration to issue regulations to ensure patients receive timely, consistent, and accurate information with their prescription drugs. The legislation would ensure patient medication information is regularly updated as new information becomes available and ensure that common information is applied consistently across similar products. Most importantly, the legislation would ensure patients are kept up to date about potential adverse side effects and dangerous drug interactions.

BREAK IN TRANSCRIPT

Mrs. GILLIBRAND. I appreciate the Chairman's support and hope to work with him to advance this legislation. I also hope he will join me in calling on the FDA to use its existing authority to ensure patient medication information is uniform, accurate, and up-to-date. The FDA is currently engaged in efforts to revise the patient education materials that are distributed to patients. However, the FDA's current plan falls short of ensuring that consumers will receive unbiased and accurate information about their prescription drugs. It also fails to ensure that patient medication information is consistent for identical or similar products.

BREAK IN TRANSCRIPT

Source